~~<i id='191CB94441'><strike id='191CB94441'><tt id='191CB94441'><pre id='191CB94441'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：knowledge 2025-09-06 04:41:12 - browse：8712

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Bird flu in dairy cattle: New measures to control spread to humans

explore

focus

hotspot

explore

entertainment

AdobeAtitssurface,itseemslikeasimpleproblemwithasimplesolution.Acrossthecountry,medicinecabinetsarel

WSS

Congress considering partial increase for doctor pay in Medicare

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Trial using CRISPR to edit HIV out of cells disappoints

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

ACIP vaccine advisory panel sees its vacancies filled

Tome Biosciences co

focus

leisure time

explore

Sports medicine is finally prioritizing gender equality

UnitedHealth, in a surprise, takes aim at Steward’s physician group

In Memoriam: Notable people who died in 2023

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Duchenne breakthrough therapy leaves behind pioneering families

Abbott's new heart device gets FDA advisory panel nod

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Why Eli Lilly’s earnings didn’t quite live up to the hype

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Bernie Sanders gets little from pharma CEOs on drug prices

focus

Congress considering partial increase for doctor pay in Medicare

Bird flu reported in person exposed to presumably infected cattle

Four alarming medical procedures we’re glad history forgot

Ebola vaccine can save some who are already sick, per new study

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Juul documents reveal insider tactics on political lobbying

focus

hotspot

explore

entertainment